Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
44,328
44,328
41,950
40,109
43,653
43,075
Revenue Growth (YoY)
6%
6%
5%
-8%
1%
24%
Cost of Revenue
19,203
19,210
18,644
17,919
19,083
18,490
Gross Profit
25,125
25,118
23,306
22,190
24,570
24,585
Selling, General & Admin
12,217
12,220
11,651
10,883
11,109
11,217
Research & Development
2,871
2,889
2,784
2,619
2,741
2,733
Operating Expenses
16,770
16,791
16,313
15,468
15,863
15,997
Other Non Operating Income (Expenses)
708
713
558
518
366
277
Pretax Income
8,466
8,466
7,013
6,664
8,306
8,211
Income Tax Expense
1,942
1,942
-6,389
941
1,373
1,140
Net Income
6,524
6,524
13,402
5,723
6,933
7,071
Net Income Growth
-51%
-51%
134%
-17%
-2%
56.99%
Shares Outstanding (Diluted)
1,744.51
1,748
1,748
1,749
1,764
1,789
Shares Change (YoY)
0%
0%
0%
-1%
-1%
0%
EPS (Diluted)
3.73
3.73
7.67
3.27
3.93
3.95
EPS Growth
-51%
-51%
135%
-17%
-1%
56.99%
Free Cash Flow
7,395
7,395
6,351
5,059
7,804
8,648
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
56.67%
56.66%
55.55%
55.32%
56.28%
57.07%
Operating Margin
18.84%
18.78%
16.66%
16.75%
19.94%
19.93%
Profit Margin
14.71%
14.71%
31.94%
14.26%
15.88%
16.41%
Free Cash Flow Margin
16.68%
16.68%
15.13%
12.61%
17.87%
20.07%
EBITDA
11,471
11,443
10,211
9,965
11,974
12,126
EBITDA Margin
25.87%
25.81%
24.34%
24.84%
27.42%
28.15%
D&A For EBITDA
3,116
3,116
3,218
3,243
3,267
3,538
EBIT
8,355
8,327
6,993
6,722
8,707
8,588
EBIT Margin
18.84%
18.78%
16.66%
16.75%
19.94%
19.93%
Effective Tax Rate
22.93%
22.93%
-91.1%
14.12%
16.53%
13.88%
Follow-Up Questions
What are Abbott Laboratories's key financial statements?
According to the latest financial statement (Form-10K), Abbott Laboratories has a total asset of $86,713, Net profit of $6,524
What are the key financial ratios for ABT?
Abbott Laboratories's Current ratio is 2.5, has a Net margin is 14.71, sales per share of $25.35.
How is Abbott Laboratories's revenue broken down by segment or geography?
Abbott Laboratories largest revenue segment is Established Pharmaceutical Products, at a revenue of 5,536,000,000 in the most earnings release.For geography, United States is the primary market for Abbott Laboratories, at a revenue of 17,126,000,000.
Is Abbott Laboratories profitable?
yes, according to the latest financial statements, Abbott Laboratories has a net profit of $6,524
Does Abbott Laboratories have any liabilities?
yes, Abbott Laboratories has liability of 34,583
How many outstanding shares for Abbott Laboratories?
Abbott Laboratories has a total outstanding shares of 1,736.59